Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Svennilson Peter
Relationship:   Director, 10% Owner
City:   Seattle
State:   WA
   
Insider Summary:
  
   
Companies Owned :   8    
Direct Shares   21,988,435    

Indirect Shares

   28,546,447      
Direct Value   $116,340,434    

Indirect Value

   $269,383,338      
Total Shares   50,534,882      
Total Value   $385,723,772      


Constellation Pharmaceuticals Inc $87,862,688 Ngm Biopharmaceuticals Inc $27,702,818 Revolution Medicines, Inc. $774,927 Nurix Therapeutics, Inc. $0 Constellation Pharmaceuticals Inc $87,862,688 Ngm Biopharmaceuticals Inc $27,702,818 Revolution Medicines, Inc. $774,927 Nurix Therapeutics, Inc. $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    32   
    4    

     Stock price went up :
    32   
    1    
     Stock price went down :
    0   
    3    
   
     Gain/Loss Ratio :
   32.0   
   32.0   
     Percentage Gain/Loss :
   66.6%
 -51.4%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Immune Design Corp. IMDZ Managing Partner, 10% ... 2019-04-02 0 2017-10-27 6,642,942    Premium*  
            Constellation Pharmaceuticals Inc CNST 10% Owner 2021-02-17 2,584,957 2021-02-17 3,645,681    Premium*  
            Gritstone Oncology, Inc. GRTS Director, 10% Owner 2018-10-02 0 2018-10-02 3,102,934    Premium*  
            Ngm Biopharmaceuticals Inc NGM Managing Partner, 10% ... 2020-08-28 17,988,843 2020-08-28 190,000    Premium*  
            Oric Pharmaceuticals, Inc. ORIC Director, 10% Owner 0 2020-04-28 4,768,181    Premium*  
            Revolution Medicines, Inc. RVMD Director 2021-04-28 20,302 2021-04-28 3,145,258    Premium*  
            Nurix Therapeutics, Inc. NRIX 10% Owner 2021-05-05 1,394,333 2021-05-05 1,420,954    Premium*  
            Rapt Therapeutics, Inc. RAPT Director, 10% Owner 2020-08-17 0 2020-09-22 5,630,497    Premium*  
* Premium Members only  

Records found :    116         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 3 of 5
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-10-15 4 B $10.31 $342,292 I/I 33,200 16,288,179 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-10-16 4 B $10.26 $358,074 I/I 34,900 16,323,079 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-10-17 4 B $10.62 $72,407 I/I 6,818 16,329,897 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-10-18 4 B $11.29 $392,000 I/I 34,721 16,364,618 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-10-21 4 B $11.94 $518,196 I/I 43,400 16,408,018 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-10-22 4 B $12.00 $27,600 I/I 2,300 16,410,318 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-10-23 4 B $11.86 $24,752 I/I 2,087 16,412,405 2.17 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-11-04 4 B $11.99 $100,824 I/I 8,409 16,420,814 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-11-11 4 B $12.00 $180 I/I 15 16,420,829 2.17 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2020-02-06 4 B $15.96 $716,604 I/I 44,900 16,465,729 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2020-02-26 4 B $18.00 $67,518 I/I 3,751 16,469,480 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2020-02-27 4 B $17.91 $607,077 I/I 33,896 16,503,376 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2020-02-28 4 B $17.91 $676,998 I/I 37,800 16,541,176 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2020-03-02 4 B $17.90 $252,820 I/I 14,124 16,555,300 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2020-03-03 4 B $17.99 $697,256 I/I 38,758 16,594,058 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2020-03-04 4 B $17.96 $179,349 I/I 9,986 16,604,044 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2020-03-05 4 B $18.00 $149,526 I/I 8,307 16,612,351 2.25 %
CNST Constellation Pharmaceuti... Managing Partner   –       –       •   2020-03-19 4 B $22.38 $808,701 D/D 36,135 6,045,837 2.45 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2020-03-19 4 B $11.59 $1,720,698 I/I 148,464 16,760,815 2.25 %
CNST Constellation Pharmaceuti... Managing Partner   –       –       •   2020-03-20 4 B $23.15 $128,228 D/D 5,539 6,051,376 2.45 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2020-03-20 4 B $11.77 $1,684,075 I/I 143,082 16,903,897 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2020-03-23 4 B $11.63 $1,981,601 I/I 170,387 17,074,284 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2020-03-24 4 B $12.22 $1,568,767 I/I 128,377 17,202,661 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2020-03-25 4 B $12.49 $30,176 I/I 2,416 17,205,077 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2020-03-31 4 B $12.53 $1,479,380 I/I 118,067 17,323,144 2.25 %
  116  Records found
  1   2   3  4   5      
  Page 3 of 5  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us